Introduction
In recent years, improvements in the identification of risk factors, earlier diagnosis and new treatments have resulted in an increase of the number of cancer patients living longer; even in the case of malignancies that cannot be cured, but can be controlled, current treatments enable many patients to live for years after the diagnosis.
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PUBLIC INTEREST STATEMENT
Novel therapies and prevention strategies have led to the idea that cancer can be considered a chronic disease. Viewing cancer as a chronic disease clearly changes the care flow pattern and shapes the point of view of both physicians and patients.
The authors tried to find out whether and to what extent the scientific community recognizes cancer as a chronic disease and how it is defined. Having a shared and common definition of chronic cancer might help physicians to have a common background in taking shared medical decisions and to better communicate with patients. It would also help patients to recognize their own needs more fully, depending on the disease phase that they are experiencing. daily living.". (Goodman et al., 2013) Certainly, some advanced cancers, such as chronic myelogenous leukaemia (CML) (Pulte, Redaniel, Bird, & Jeffreys, 2015) meet the criteria in terms of duration, the need for ongoing medical treatment and functional impairment. However, a 12-month criterion for a disease to be chronic is possibly not applicable to the field of cancer care. This is first because in the case of some malignancies the situation may unpredictably worsen within time, and secondly because, as mentioned previously, patients diagnosed with cancer, unlike patients with other well-known chronic conditions, may believe that a cure is possible.
A description provided by the American Cancer Society (2013) lists some features of CC, characterizing it as an advanced cancer that can be managed for months or even for years, that can become stable using treatments or enter a repeating cycle of remission and recurrence.
Even if such a definition offers some important boundaries for identifying what a CC should "look like", several particular aspects of cancer still render its shift into a "chronic condition" problematic (Tritter, 2002) .
Cancer is a cellular categorization, rather than a singular entity or disease, and it encompasses a broad range of illnesses. This means that it is very hard to provide a list of unique features for a "template" of cancer to be considered chronic, since there are many diseases/cancers (lung, breast, ovarian, bowel, etc.) , and many different illnesses affecting the same localization (e.g., mesothelioma, small cell lung cancer, etc.). Each disease has different incidences, mortality rates and may require treatments that differ markedly. Furthermore, the predictability of treatments and prognosis even in the light of the same microscopic characteristics is rather low compared to other chronic diseases (Hebdon, Foli, & Mccomb, 2015; Tritter, 2002) .
We dare say that patients' common-sense definition and that of oncologists differ markedly so that a potentially insidious misunderstanding occurs. For example, after a recurrence of an ovarian cancer, the oncologist may tell the patient that no more curative intent is available and that they will try to "chronicize" the cancer. Patients usually understand that they are to live with ovarian cancer from that point on, as would be the case with a diabetes diagnosis. However, the median overall survival after the first, second, third, fourth and fifth ovarian cancer relapse (Hanker et al., 2012) is very different from that associated with diabetes or asthma.
Given the importance of a definition for the health-care flow and for the patients' mindset, to shed light on the definition of chronic cancer(s), papers dealing with the concept of cancer as a chronic illness were systematically reviewed to find out whether and to what extent a shared definition of cancer as a chronic disease can be found in the literature.
Methods

Selection procedures and data collection
2.1.1. Search strategy A comprehensive literature search was designed and conducted by an experienced medical librarian (WRE) with input from the study investigators. We searched the electronic databases Ovid MEDLINE, Embase, Scopus, Pubmed and ProQuest Psychology. Various combinations of database-specific controlled vocabulary (subject headings) were used, supplemented by keywords, title and abstract terms for the concepts and synonyms relating to chronic cancer and its definition. Bibliographies of relevant papers were examined and citing articles were identified using ISI Web of Science. English language restrictions were applied, and the date restriction was from 1980 onwards. The full search strategies employed are reported in the Table A1 .
Inclusion criteria
Articles included for the systematic review dealt with the concept of CC as they (a) clearly attempted to give a general definition of CC, (b) stated that some specific cancers must be defined or considered as chronic diseases, (c) considered some clinical issues regarding cancer patients within a framework of chronicity, giving some specific attributes or definition of CC.
All the included articles were written in English and dealt with human cancers.
The search results are summarized in the (Prisma) Flow Chart in Figure 1. 
Exclusion criteria
Articles excluded from the review were: (i) duplicates, (ii) articles that did not provide any definition or description of what they considered as CC or of which attributes are related to CC.
Included studies
A total of 510 studies were identified through the initial search strategy from databases, 451 were removed by after examining the title and abstract.
A total of 40 were excluded as they did not provide an explicit definition or specific criteria to explain or characterize cancer as a chronic illness. Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) (Moher, et al., 2009) .
A total of 19 of the studies identified through the initial search were included in the review and 9 additional studies that met the inclusion criteria were found through a manual search of the bibliography of the initial relevant studies. In all, 28 articles were included in the present review.
Results
Study characteristics
Overall, 28 studies were included in the present review.
Among the included articles, there are four reviews, one concept analysis, 17 editorials, commentaries, special issues or theoretical articles, four cross-sectional or longitudinal studies on cancer patients, and two case studies.
Overall, two studies explicitly attempted to define CC, while there were nine articles stating that some specific cancer types may be considered as chronic illnesses. Sixteen articles listed cancer or some specific cancer types as chronic disease, giving a detailed description of what or why they considered cancers disease to be chronic.
CC features
Overall, each one of the included articles provided some attributes or criteria for CC.
Considering the American Cancer Society (2013) regarding CC, a list of characteristics of CCs was drawn up. Definitions or descriptions of the features of CC provided by relevant articles were organized according to those specific features.
The first key feature we identified from the American Cancer Society statement (2013) was (i) cancer stage (advanced or metastatic); the second referred to the possibility of healing or not (ii) curative intent; the third related to the fact that existing treatments may allow for symptom control, rendering CC manageable (iii) symptom control and the fourth dealt with the presence of (iv) cycle of remission and recurrence. The last category refers to the time dimension and to the possibility of a long-term survivorship (v) estimated survival.
Descriptions of relevant articles were organised according to those key features in Table 1 , to highlight which characteristics were represented the most in the literature and to assess whether and to what extent some shared characteristics of what is considered CC can be determined in the literature. Studies' characteristics and the extent to which they overlap with the definition provided by the American Cancer Society (on a scale from 1 to 5 point, representing the key features aforementioned) are reported in Table 2 .
Overall, 23 articles recognized time criterion (estimated survival) as a CC characteristic, while 10 identified the presence of cycle remission and recurrence in CCs. There were nine articles which listed symptom control and seven mentioned cancer stage as relevant aspects of CC, while five articles addressed the curative intent dimension of CC.
General CC definitions
In 1953, Morton and Morton summarized clinical cases with cancers behaving as chronic diseases, showing that chronicity was not related to a specific cancer type (1953).
Within a chronic disease framework, Dorsett (1991) analyses the trajectory of cancer recovery, considering cancer a chronic disease characterized by episodic and acute morbidities, with the possibility of more prolonged remission compared to the past.
During an anthropological analysis on chronic illnesses, Heurtin-Roberts and Becker (1993) include cancer as a chronic condition and define chronic illnesses as health conditions that can be managed over time, but not cured, and that have periodic or ongoing symptoms. Authors referred in particular to the Kagawa-Singer paper, (1993) that examines how a sample of cancer patients, viewed as chronic patients, can live with a particular state of health, unlike health definitions commonly used in health-care settings. The majority of the sample is composed of breast cancer and colorectal cancer patients; the remaining patients had cancers of various sites.
For Walker (2001) according to the improvement of cancer survival rate, some cancers, such as those of the cervix, prostate and oesophagus, are more probably to be included among chronic diseases, than among terminal ones. Possible distinguishing features of chronicity, according to the author, may be duration, the insidious and incurable nature of the disease and its periodic, episodic or recurrent nature (2001).
In a commentary on childhood cancer, D'Angio (2007) wrote that some malignant entities that typically have a prolonged course, might be labelled as chronic in a proper way, thus referring the "chronicity" label to diseases with favourable survival rates. The author lists mesenchymal chondrosarcoma and alveolar soft part sarcoma as examples of malignant entities that might well be termed as chronic.
According to Berlinger and Flamm (2009) CC can be used to address advanced cancers, that cannot be cured, but can be stable or be stabilized with treatments, or cancers with cycles of recurrence, remission and treatment that can prevent cancer. Naus, Ishler, Parrott and Kovacs (2009) placed cancer survivorship within a chronicity framework, focusing on the need for a long term adjustment for cancer patients.
In a review concerning the shift of cancer from a rapidly fatal disease to a chronic condition, Lage and Crombet (2011) trace lines of evidence of a transition of advanced cancers to chronicity in the improvement of long term survival rates (2011). According to Phillips and Currow (2010) living as a cancer survivor means living with a chronic recurrent or ongoing condition. According to Berlinger and Gusmano (2011) some incurable but treatable cancers, could potentially be considered as CCs and be managed as chronic conditions by the patient's self-management as his or her own principal caregiver. CML is recognized by the authors as a disease that fits easily into a category of chronic disease (2011).
McCorkle et al. (2011) analysing self-management needs of patients living with cancer as a chronic condition, state that, as patients are living longer, cancer may be managed as a chronic illness occurring on a continuum that runs from prevention to end of life. Harley et al. (2012) built up a "working definition" of CC, identifying boundaries to establish when the chronic phase of cancer begins or ends in selected breast, renal, colorectal, gynaecological and prostate cancer patients.
The principal point listed by Harley et al. (2012) relates to the fact that CC is a cancer that cannot be cured, but it is active, advanced or metastatic and can be managed with treatments that lead to slow disease progression, symptom control and prolonged life. When patients are likely to have only months of survival and no treatments still exist, the chronic phase ends (2012). Gosain and Miller (2013) in a review on symptom management in long-term cancer survivors, described a phase of chronic cancer survivorship as a phase in which patients live with a CC that may be either on an ongoing remission or active but controlled.
In a 2015 concept analysis on survivor in cancer context Hebdon, Foli and McComb (2015) , highlight that the most descriptive term in the context of cancer is "malignancy", a category that includes carcinoma, sarcoma, leukaemia, lymphoma and central nervous system cancers. The authors also discussed the variability within cancer patients (Hebdon et al., 2015) , who have different personal experiences within the cancer care flow continuum, needing individualized care.
Boerger-knowles and Tashi (2015) focusing on the fact that living with CC often causes functional and relational changes, explicitly reported the American Cancer Society (American Cancer Society, 2013) definition in the introduction of their manuscript, stating what they considered to be CC. Authors also described cases with recurrence and remission.
According to Sutton (2016) , non-melanoma skin cancer can be considered chronic diseases in a specific subgroup of patients, as it meets the US Department of Health & Human Services definition of chronic disease (Goodman et al., 2013) by reason of its prolongation, need for ongoing medical care and for the functional damage it causes. Frick et al. (2017) identify the category of CC survivors in those patients living with a metastatic or recurrent cancer or new diagnosis of a second cancer, as well as those who had a diagnosis of chronic lymphocytic leukaemia (CLL) or CML, at least at two years from their diagnosis. The greatest percentage of CC survivors identified is composed of breast cancer patients (2017).
Specific CC definitions
Breast, ovarian and prostate cancer have been identified as chronic cancers by several authors.
According to Polinsky (1994) , long-term breast cancer survivors (from 16 months to 32 years from their original surgery) live a chronic illness characterized by lifelong follow up medical care. Reed and Corner (2015) explore the illness trajectory of metastatic breast cancer patients, that ranged from 13 months to 5 years and 9 months, concluding that metastatic breast cancer is increasingly becoming of a chronic nature. A 2015 comprehensive review dealing with breast cancer survivorship (Bodai & Tuso, 2015) assesses long term medical and lifestyle issues, considering breast cancer as a CC because it leads to long term survivorship.
For ovarian cancer, the median survival range of 12 to 24 months of patients with recurrent ovarian cancer is said by Armstrong (2002) to demonstrate that the disease has a "chronic natural history".
In a 2006 editorial, Markman (2006) stated that ovarian cancer can be considered a CC, due to the fact that for a significant percentage of ovarian cancer patients the disease can recur, and the patient becomes a prolonged survivor whose life expectancy may be measurable in years and for whom cure is not a plausible aim (2006) .
In a subsequent case study, Markman and Malviya (2008) report the 11-year survival of a woman with recurrent advanced epithelial ovarian cancer, underlining that it can be considered chronic in nature.
Finally, as regards prostate cancer, Doyle-Lindrud (Doyle-Lindrud, 2007) concludes that prostate cancer possesses a chronic nature that needs extensive medical management. Guttilla, Bortolami, and Evangelista (2015) summarized and evaluated cost-effectiveness and follow-up of prostate cancer as a chronic disease, stating that this oncological condition can be considered chronic, because of its long median survival (42 months).
Hematologic cancer has also been considered as a chronic condition. According to DePue (2008), many hematologic cancers (i.e. multiple myeloma) are now perceived as chronic conditions, as a result of multiple therapies that allow a longer survival.
Discussion
Even though there appears to be no unique and common definition of chronic cancer emerging from the relevant published medical literature, a certain degree of overlap can be observed between the attributes of CC and with the description given by the American Cancer Society (2013).
It is not surprising that only certain CC features are reported and discussed by the selected articles, as the aim of most the papers was not to provide an explicit and complete definition of what CC is.
Overall, most of the articles recognized a time criterion for a CC definition, i.e. the estimated survival, and almost all the articles that identify a specific cancer type as a CC, made use of a time criterion. In a longitudinal perspective, beginning with cancer diagnosis itself, it seems that the term "chronic" fits well with the recognition of a specific phase in the cancer trajectory more than as an attribute of the cancer itself.
According to selected articles, the time course for a cancer to be considered chronic ranged from months to years of survival, with the end of the chronic phase being placed when the patient, as referred to by Harley et al. (2012) had only months to live. Although the majority of the articles identified "time to live" as a basic criterion for CC, no common start and endpoint emerged and, as Harley and colleagues noted, the lack of a shared definition of when the chronic cancer phase should begin or end, poses some difficulties in defining what is a CC in a unique way (2012). Thus, it emerges from the literature that cancer can be defined as "chronic" on the basis of the characteristics of some of its phases and not as a chronic illness itself such as asthma or diabetes. Noteworthy, as it is difficult for oncologists to predict cancer time course and knowing disease duration a priori, it is hard to establish when the chronic care phase should begin for the specific patient.
Furthermore, as mentioned in the introduction, a 12-month criterion for a disease to be chronic may not be appropriate in the field of cancer care, as in the first treatment year, many particular difficulties may arise.
The initial diagnosis of cancer often requires a substantial and immediate treatment (e.g., in the case of liquid tumours), in contrast to the typical responses to a chronic disease (Bell & RistovskiSlijepcevic, 2013) ; in addition, a tumour may respond unpredictably to treatment and may display a significant capacity to change (Berlinger & Flamm, 2009) .
Cancer is still associated with mortality by newly-diagnosed patients (Tritter, 2002) . Few other chronic illness diagnoses raise such strong concerns about death, rendering the diagnosis of cancer a very stressful event, both for the patients and their family.
Finally, considering the model of chronic illness trajectories (Wellard, 1998) , there are other huge differences between cancer and other chronic illnesses. Register (1987) described chronic illness as involving a first adjustment phase defined as "legitimization of symptoms": this is not the case for cancer patients for whom the initial psychological burden is that of processing the socially recognized life-threatening nature of diagnosis and of nurturing hope regarding the possibility of being cured.
The presence of cycles of remission and recurrence and the possibility of controlling symptoms were reported by almost one-third of relevant articles. Existing treatment options that allow for cancer stabilization and its cyclic nature were considered as salient attributes of CC.
Thus, according to studies emerging from the medical literature, cancer as a chronic disease is something that can be medically controlled and managed for a certain time extent or that can present a recurrent form.
Importantly, only certain cancer types may be included in these criteria, as most cancers, unlike other chronic illnesses, can become resistant to the treatment and adapt themselves (Berlinger & Flamm, 2009) , with a capacity to change that is the norm rather than the exception (2009).
In terms of cancer stage and the goal of treatment, a minority of authors explicitly described CC as advanced or metastatic and as a disease that cannot be cured. Such criteria have been explored in more depth by certain authors probably as a result of the heterogeneity of cancer types considered in relevant articles. The heterogeneity of different cancer types (stage, site, type of cancer) is reflected also by the fact that most authors recognized different cancer forms as template or examples of CC.
According to some authors, certain specific cancer types fit better with the model of CC: breast, ovarian and hematologic cancers were those most identified (Armstrong, 2002; Berlinger & Flamm, 2009; Berlinger & Gusmano, 2011; Bodai & Tuso, 2015; DePue, 2008; Frick et al., 2017; Markman, 2006; Markman & Malviya, 2008; Polinsky, 1994; Pulte et al., 2015; Reed & Corner, 2015) .
Because the definition of CC given by the American Cancer Society (2013) encompasses a broad and heterogeneous population of patients, distinct patient groups, for instance, those with different cancer sites or those with metastatic cancers versus locally recurrent cancers, should be studied separately (Frick et al., 2017) .
When it comes to authoritative definitions, it is worth noting that authors took into consideration patients suffering from chronic cancer who received diagnosis at least from a 12 to 16 month period (Armstrong, 2002; Harley et al., 2012; Polinsky, 1994; Reed & Corner, 2015) , meeting the duration criterion listed by the US Department of Health and Human Services. Aspects related to functional limitations as well as to the need for ongoing medical treatment were also addressed or considered to some extent by a relevant number of papers (Berlinger & Flamm, 2009; Berlinger & Gusmano, 2011; Bodai & Tuso, 2015; Boerger-Knowles & Tashi, 2015; D'Angio, 2007; Dorsett, 1991; Frick et al., 2017; Guttilla et al., 2015; Harley et al., 2012; Hebdon et al., 2015; Lage & Crombet, 2011; Markman, 2006; Markman & Malviya, 2008; McCorkle et al., 2011; Reed & Corner, 2015; Sutton, 2016) , showing that, at least to some degree, the US Department definition of a chronic disease was reflected in the literature.
Overall, in terms of seeking clarity amongst the range of possible definitions, the following general and interrelated issues seem to be resolved or to have been taken into consideration in building a shared concept of what comprises CC.
There is a significant variability within different cancer types, given by the fact that "cancer" is an umbrella term for uncontrolled cellular replication, identifying a group of illnesses, rather than a unique condition (Hebdon et al., 2015; Tritter, 2002) : different cancers may behave in very different ways throughout time, and different sites and stages define different populations of patients (Frick et al., 2017) . The American Cancer Society's definition itself encompasses different cancer types, such as ovarian cancer, chronic leukaemias, and some lymphomas, as well as metastatic breast or prostate cancer (2013).
There are also chronic changes associated with therapies: cancers may modify themselves with unpredictable cellular proliferation (Berlinger & Flamm, 2009; Berlinger & Gusmano, 2011) , leading to a random growth and to unstable responses to therapies. Furthermore, cycle of recurrence and remission may take place. Acute episodes may occur many times, rendering it difficult to apply a consistent label to cancer as "chronic".
In the cancer trajectory, there are some chronic and some acute phases, therefore, it is not possible to talk about cancer as a chronic disease in its entirety, rather it is possible to identify a chronic phase in cancer course. Furthermore, acute episodes that usually occur during the "chronic" phase, leading to a repetition of acute and chronic phases, provoke a continuous shift in the patient's self-perception of his/her illness (Tritter, 2002) .
Moreover, the features associated with CC, are very broad characteristics, with ambiguous boundaries. It is difficult to define a long-term survivorship or to define in a unique way the fact that a cancer may be controlled but not cured or to what extent symptoms are truly controlled.
Another point worthy of emphasis centres on the impact of using the adjective "chronic" in cancer care considering the patient-health-care provider relationship and communication issues: very often, cancer patients in their 50s and 60s are also affected by some other chronic conditions such as cardiovascular disease or diabetes. If their cancer recurs or is advanced at diagnosis, when they hear their oncologists talk also about their cancer as a chronic condition, a misunderstanding is created because they overlap the model of chronicity that pertains to diabetes with that which pertains to cancer. It is well-known that cancer treatments exert a more profound impact on quality of life than do treatments for other chronic conditions. Finally, it is hard to establish which features of CC are necessary and sufficient for a cancer to be defined as chronic, since all the aspects listed in the medical literature are characteristics that a CC may possess, and not the characteristics that a CC must possess. This further serves to render the CC label susceptible to a certain vagueness and confusion.
Conclusions
To some extent, the features associated with the concept of CC in the literature overlap with one another and with the American Cancer Society (2013) statements on chronic tumours. There is also a certain degree of overlap between official definitions of a chronic disease (US Department of Health and Human Services, 2010; WHO, 2015) and the attributes of CC.
Implications for psychosocial oncology
The relevant heterogeneity within the definition of CC and the issues highlighted in the literature deserve attention. The label "chronic" should be used with caution. Indeed, besides the attributes and definitional issues pertaining to specific cancers, it is worthy of note that many authors also discuss the problematic issues in the transition of cancer into a chronic condition.
The scientific community should explore whether it makes sense to talk about the presence of a cancer phase with chronic characteristics rather than talk about cancer as a chronic condition itself. Including the model of chronicity in cancer care implies implementing and delivering specific training modules in communications skills to health-care professionals (Arnaboldi & Pravettoni, 2016) to face the issue of survival with long-lasting and demanding therapies, impaired quality of life and a non-defined temporal horizon.
When patients enter the "no longer curative phase", oncologists have an important issue to overcome. With the number of drugs at their disposal that could improve survival for months and sometimes even years, they have to deal with the hope for cure of their patients. It is the case of patients whom they follow for months, even years and with whom a therapeutic relationship is always started. It happens that oncologists start speaking to their patients of the main treatment purpose being "to chronicize" their illness. In the mind of patients, hearing the term "chronic" as applied to cancer activates some cognitive maps that relate cancer to the course of other chronic illnesses such as diabetes and asthma. On the other hand, evidence from the literature affirms that the number of deaths following the cancers mentioned above did not decline regardless of the prevalence. This becomes a communication bias that creates a cognitive dissonance in the patient's mind: patients feel reassured being told their cancer could be chronic (like diabetes and asthma) but they are also scared because they are confronted on a daily basis with people dying from the very same condition with which they are affected. This is a heavily demanding task for the team members who in the majority of cases have followed their patients for years along multiple chemotherapy regimens and life hopes. In some cases, the utilization of "chronic" as an adjective in cancer care may be more the result of an affective predisposition aimed at sharing hope rather than the result of a medical evidence. However, given the severity of cancer, there is a greater importance now ever before that CC patients receive the close attention they deserve, focusing on personal experiences and building personalized patterns of care aimed at the true empowerment of patients (Bailo, Guiddi, Vergani, Marton, & Pravettoni, 2019) .
Key messages
• There is a relevant heterogeneity within the definition of CC employed in literature
• As cancers' shift into a chronicity framework presents several issues, the label "chronic" should be used with caution
• The scientific community should explore whether it makes sense to talk about the presence of a cancer phase with chronic characteristics rather than talk about cancer as a chronic condition itself
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